INDIA REID: Open Payments
NPI 1922114628 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 17 payments from 8 companies in 2025. Trend: 2023 $460 · 2024 $154 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $98 |
| Indivior Inc. | 3 | $79 |
| Alkermes, Inc. | 3 | $54 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $23 |
| ABBVIE INC. | 1 | $14 |
Products named: HETLIOZ, SUBLOCADE, UZEDY, ARISTADA, INVEGA SUSTENNA, INGREZZA, VIVITROL, ABILIFY MAINTENA.
Industry payments across NC — which companies pay providers there.
